Livewire Christmas | Livewire
Livewire gives readers access to information and educational content provided by financial services professionals and companies (”Livewire Contributors”).
5 shocking predictions for 2025 and beyond - Sara Allen | Livewire
Sep 17, 2024 · Prediction 5: A structural bear market is looming. Expert: Matthew Kidman, Principal & Portfolio Manager, Centennial Asset Management "What you would know as a bull market is a market that has risen up 20% from the bottom and a bear market is a fall by 20%," says Kidman, but there's a difference when it comes to a structural market cycle.
ASX News Daily, Investment Insights, Market Analysis | Livewire
Livewire Markets offers investment insights, market analysis, and finance news from Australia's leading fund managers and professionals.
Livewire Live | Livewire - Livewire Markets
Livewire gives readers access to information and educational content provided by financial services professionals and companies (”Livewire Contributors”).
Small caps: An election trump card for 2025? - Livewire
Nov 22, 2024 · Another is SciDev (), which has water treatment technology.This is a micro-cap stock that has barely any sell-side broker coverage, and its core business in providing friction reduction for oil and gas companies in the US will be a big winner given Trump is …
How much higher can the US stock market go in 2025?
Dec 13, 2024 · Barely a day goes past that we don’t hear about how the bull market in US stocks can’t possibly continue. Gross historical overvaluations, extreme concentration of gains among the biggest capitalisation stocks (the so-called Magnificent 7 of Alphabet (Google), Amazon, Apple, Meta Platforms, Microsoft, Nvidia, and Tesla), and an …
A once in three-decade type of opportunity - Ally Selby | Livewire
Nov 18, 2024 · June-Yon Kim: In a word, I think this is probably the best opportunity we've seen in nearly three decades. Japan has been a country that has been stuck in deflation for nearly three decades and has had to overcome a significant amount of overvaluation.
Healthcare stocks shine in a dimming economy - Livewire
Oct 8, 2024 · We see potential for the pattern to continue. Today, many small- and mid-cap biotech stocks still trade at depressed valuations. Meanwhile, the industry logged a record number of Food and Drug Administration (FDA) drug approvals in 2023, which could drive revenue expansion for the respective companies for a decade or more.
Buy Hold Sell | Livewire
Marcus Today's Henry Jennings and Atlas' Hugh Dive sort through the equity rubble of 2024, hunting for beaten-up stocks set to bounce.
It's time for a change - Darren Langer | Livewire
Dec 11, 2024 · After years of sharp analysis and spirited debates, Jessica Ren and I sign off for the very last time in the final episode of The Rate Debate. From resilient labour markets and rising public spending to Fixed Income opportunities, Jess …